Quentriva

Technology Finance Sports Entertainment Lifestyle
Technology Finance Sports Entertainment Lifestyle
NIH's Grant Cap Proposal Faces Diverging Opinions from the Research Community Technology

NIH's Grant Cap Proposal Faces Diverging Opinions from the Research Community

The NIH's recent proposal to limit the number of grants per researcher has sparked varied responses, highlighting ongoing concerns in the biomedical research arena.

September 01, 2026
MAHA's Nutrition Initiatives Face Challenges Due to Dietitian Shortage Finance

MAHA's Nutrition Initiatives Face Challenges Due to Dietitian Shortage

MAHA's efforts to reshape American nutrition encounter hurdles stemming from a declining dietitian workforce.

September 01, 2026
New Migraine Prevention Guidelines Expand Treatment Options for Patients Finance

New Migraine Prevention Guidelines Expand Treatment Options for Patients

Updated guidelines from leading headache organizations emphasize new migraine treatments while addressing gaps in patient awareness and access.

August 31, 2026
Novartis Drug Pacibekitug Shows Promise in Reducing Inflammation for Heart Disease Technology

Novartis Drug Pacibekitug Shows Promise in Reducing Inflammation for Heart Disease

Novartis' latest drug, pacibekitug, successfully reduces inflammation in a Phase 2 study, suggesting potential for cardiovascular treatment.

August 29, 2026
Balancing Public Scrutiny and Maternal Mental Health Treatment After the Clancy Case Technology

Balancing Public Scrutiny and Maternal Mental Health Treatment After the Clancy Case

The Lindsay Clancy case highlights systemic flaws in maternal mental health care, raising concerns about its impact on psychiatrist willingness to treat patients.

August 28, 2026
Alnylam Eyes AstraZeneca and Ionis Heart Drug Setback as Industry Watches Closely Technology

Alnylam Eyes AstraZeneca and Ionis Heart Drug Setback as Industry Watches Closely

AstraZeneca and Ionis' heart disease treatment faced an unexpected failure, raising concerns and interest among biotech competitors like Alnylam.

August 28, 2026
Disputed Vaccine Theories Resurface in Federal Autism Committee Meeting Sports

Disputed Vaccine Theories Resurface in Federal Autism Committee Meeting

Members of a federal autism advisory committee controversially endorse vaccines as a cause of autism, despite overwhelming scientific refutation.

August 28, 2026
AstraZeneca's Heart Drug Trial Fails; Court Upholds FDA's Drug Shortage Ruling Technology

AstraZeneca's Heart Drug Trial Fails; Court Upholds FDA's Drug Shortage Ruling

AstraZeneca's heart disease trial disappoints, showing no added benefit, while a court affirms FDA's handling of drug shortages for prominent diabetes treatments.

August 28, 2026
Cytokinetics Advances Aficamten for Non-Obstructive Hypertrophic Cardiomyopathy Approval Technology

Cytokinetics Advances Aficamten for Non-Obstructive Hypertrophic Cardiomyopathy Approval

Cytokinetics is set to submit aficamten for FDA approval, potentially the first drug approved for non-obstructive hypertrophic cardiomyopathy.

August 28, 2026
AstraZeneca's Heart Study Failure Raises Questions for ATTR-CM Drug Strategies Technology

AstraZeneca's Heart Study Failure Raises Questions for ATTR-CM Drug Strategies

AstraZeneca's recent heart disease trial failure underscores the effectiveness of stabilizers over silencers for treating ATTR-CM.

August 28, 2026
Public Concerns Over Vaccine Autism Link Resurface in Federal Advisory Committee Finance

Public Concerns Over Vaccine Autism Link Resurface in Federal Advisory Committee

The federal autism advisory committee discusses vaccines as potential autism triggers, sparking controversy amidst calls for more research and transparency.

August 28, 2026
Reflections on Leaving the CDC: A Call for Public Health Reform Technology

Reflections on Leaving the CDC: A Call for Public Health Reform

A year after resigning from the CDC, former staff members highlight ongoing issues and advocate for a reformed public health system free from political bias.

August 28, 2026
FDA Greenlights Roivant's Lisraya for Dermatomyositis Treatment Technology

FDA Greenlights Roivant's Lisraya for Dermatomyositis Treatment

Roivant's new therapy, Lisraya, recently approved by the FDA, offers a non-steroidal option for treating dermatomyositis.

August 27, 2026
Kennedy's Vaccine Misinformation Sparks Tensions Following Measles Deaths in Pennsylvania Technology

Kennedy's Vaccine Misinformation Sparks Tensions Following Measles Deaths in Pennsylvania

Health Secretary Robert F. Kennedy Jr. faces backlash over vaccine misinformation as PA confirms measles-related deaths; tensions escalate with state officials.

August 26, 2026
Evaluating Heart Risk: The Role of Calcium Scans in Statin Decisions Finance

Evaluating Heart Risk: The Role of Calcium Scans in Statin Decisions

Recent studies highlight how coronary artery calcium scans can inform statin treatment decisions, especially in borderline risk cases.

August 26, 2026
‹ 1 2 3 4 5 6 7 8 9 10 … 28 29 ›

Quentriva delivers timely, accurate, and comprehensive news coverage for readers worldwide.


About Contact Privacy Terms Editorial Policy Ad Disclosure Disclaimer

© 2026 Quentriva. All rights reserved.